| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 19 |
| 1 | ASPIRIN 325 MG | 19 |
| 2 | ASPIRIN 81 MG | 19 |
| 3 | ASPIRIN 81MG | 19 |
| 4 | FUROSEMIDE | 14 |
| 5 | SIMVASTATIN | 13 |
| 6 | ONDANSETRON HYDROCHLORIDE | 12 |
| 7 | CLOPIDOGREL | 11 |
| 8 | ADALIMUMAB | 10 |
| 9 | METOPROLOL TARTRATE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LONAFARNIB | 1 | 0.0455 |
| 1 | NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0294 |
| 2 | MILRINONE LACTATE | 1 | 0.0094 |
| 3 | MECASERMIN | 3 | 0.0044 |
| 4 | MONOBASIC POTASSIUM PHOSPHATE AND DIBASIC POTASSIUM PHOSPHATE | 1 | 0.0039 |
| 5 | SODIUM NITROPRUSSIDE | 1 | 0.0037 |
| 6 | ORPHENADRINE CITRATE | 1 | 0.0023 |
| 7 | NAFCILLIN SODIUM | 1 | 0.0014 |
| 8 | BIVALIRUDIN | 3 | 0.0014 |
| 9 | DISOPYRAMIDE PHOSPHATE | 1 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 33 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 23 |
| 2 | Benzodiazepine [EPC] | 18 |
| 3 | Corticosteroid [EPC] | 17 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 17 |
| 5 | Loop Diuretic [EPC] | 16 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 14 |
| 7 | beta-Adrenergic Blocker [EPC] | 12 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 11 |
| 9 | Anti-epileptic Agent [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Osmotic Diuretic [EPC] | 2 | 0.0006 |
| 1 | Anti-coagulant [EPC] | 3 | 0.0006 |
| 2 | Vitamin K [EPC] | 2 | 0.0004 |
| 3 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 2 | 0.0003 |
| 4 | beta Lactamase Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Anticholinergic [EPC] | 2 | 0.0002 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 8 | Adenosine Receptor Agonist [EPC] | 1 | 0.0002 |
| 9 | Antidote [EPC] | 1 | 0.0001 |